Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Klotho Neurosciences Inc (KLTO)

Klotho Neurosciences Inc (KLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Klotho Neurosciences Inc 1300 SOUTH BOULEVARD UNIT D CHARLOTTE NC 28203 USA

www.klothoneuro.com Employees: 3 P: 833-931-6330

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Klotho Neurosciences Inc. is a pharmaceutical company. It specializes in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system which are seen as key developments in treating neurodegenerative and age-related disorders. Klotho Neurosciences Inc., formerly known as ANEW MEDICAL INC., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 19,215
Enterprise Value, $K 19,155
Shares Outstanding, K 73,537
Float, K 66,257
% Float 90.10%
Short Interest, K 392
Short Float 0.53%
Days to Cover 1.00
Short Volume Ratio 0.44
% of Insider Shareholders 9.90%
% of Institutional Shareholders 20.07%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -6,150 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,900 K
EBIT, $ -7,280 K
EBITDA, $ -7,270 K

Growth:

1-Year Return -33.33%
3-Year Return -97.40%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 11/13/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -0.32
EPS Growth vs. Prev Qtr 58.33%
EPS Growth vs. Prev Year 72.22%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

KLTO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -201.60%
Return-on-Assets % -171.30%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.91
Book Value/Share 0.14
Interest Coverage -16.08
60-Month Beta 10.27
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar